Genmab ADR (NASDAQ: GMAB) is -1.68% lower on its value in year-to-date trading and has touched a low of $17.24 and a high of $30.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GMAB stock was last observed hovering at around $20.33 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $20.52, the stock is 1.00% and 3.50% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.54 million and changing 0.93% at the moment leaves the stock -7.57% off its SMA200. GMAB registered -31.55% loss for a year compared to 6-month loss of -0.34%. The firm has a 50-day simple moving average (SMA 50) of $19.8256 and a 200-day simple moving average (SMA200) of $22.201574.
The stock witnessed a 1.23% gain in the last 1 month and extending the period to 3 months gives it a -8.56%, and is 7.55% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.72% over the week and 2.18% over the month.
Genmab ADR (GMAB) has around 2682 employees, a market worth around $12.61B and $3.23B in sales. Current P/E ratio is 11.64 and Fwd P/E is 11.46. Profit margin for the company is 35.11%. Distance from 52-week low is 19.06% and -31.74% from its 52-week high. The company has generated returns on investments over the last 12 months (20.91%).
The EPS is expected to shrink by -10.12% this year
290.0 institutions hold shares in Genmab ADR (GMAB), with institutional investors hold 10.41% of the company’s shares. The shares outstanding are 635.50M, and float is at 614.73M with Short Float at 0.39%. Institutions hold 10.41% of the Float.
The top institutional shareholder in the company is ALLIANCEBERNSTEIN L.P. with over 15.24 million shares valued at $382.93 million. The investor’s holdings represent 23.4845 of the GMAB Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.08 million shares valued at $127.67 million to account for 7.8301 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.23 million shares representing 6.5161 and valued at over $108.15 million, while HARDING LOEVNER LP holds 4.2657 of the shares totaling 2.77 million with a market value of $69.61 million.
